Outsourcing

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

Podcasts

Public relations agencies dissect pharmaceutical trends: Brandwidth Solutions, Orientation Marketing and White Matter Communications

Drug Solutions Podcast: Pharma Trends Dissected by 3 PR Agency Luminaries

Meg Rivers is the former senior editor for 

In this episode of the Drug Solutions Podcast, Meg Rivers discusses outsourcing strategies in biopharma with Jeff Henderson, key account manager of Vetter.

Drug Solutions Podcast: Outsourcing vs. Insourcing in Biopharma: Determining the Best Strategy: Part 2

In this episode of the Drug Solutions Podcast, Chris Spivey interviews executives at Shabas Solutions LLC, who ran the overseas QMM pilot project.

Drug Solutions Podcast: FDA Quality Management Maturity (QMM) Overseas Pilot Program Findings: Going Beyond the Regulations

Articles

The CPHI Annual Report 2022 predicts cash reserves from venture capitalists and private equities will drive expansion in the demand for contract research organizations and contract development and research organizations.

Venture Capital Funding to Fuel Pharma Outsourcing

Under two new agreements, Societal CDMO will offer analytical, technical transfer, formulation, manufacturing, and packaging services for novel therapeutics.

Societal CDMO Signs Multiple CDMO Service Agreements

Sponsors should explore key considerations ahead of choosing a new outsourcing partner.

CPHI Frankfurt: Selecting the Right Outsourcing Strategy and Partner

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

External expertise is beneficial in helping companies select the right tools at the right stages of development to ensure success.

Adopting Smart Development Strategies

Brian Mullan is the chief technical officer of Yposkesi, an SK Pharmteco company.

Whether biologic manufacturers decide to outsource or develop products internally, the quality of a CDMO partnership is critical to success, especially for cell and gene therapy products.

Choosing the Right CDMO for CGT Programs 

The latest CPHI report has been published, predicting that a significant shift in outsourcing strategies is being experienced globally.

CPHI Report Predicts Significant Shifts in Global Outsourcing Strategies

In this episode of the Drug Solutions Podcast, John Koleng, VP of product development and manufacturing for TFF Pharmaceuticals shares outsourcing strategies in biopharma.

Contract Development Services